Nektar Therapeutics (Nasdaq: NKTR) narrowed losses for the fourth quarter to 21 cents per share from 28 cents per share in the year ago period as revenue surged. The stock price leaped $18.32 to close at $102.87.
Nektar Therapeutics narrows losses
March 02, 2018 at 18:47 PM EST
